Page last updated: 2024-11-05

thalidomide and Histoplasma capsulatum Infection

thalidomide has been researched along with Histoplasma capsulatum Infection in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azar, MM1
Malinis, MF1
Bullock, WE1

Other Studies

2 other studies available for thalidomide and Histoplasma capsulatum Infection

ArticleYear
Disseminated Histoplasmosis with Skin Lesions and Osteomyelitis in a Patient from the Philippines.
    The American journal of tropical medicine and hygiene, 2016, Jul-06, Volume: 95, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Aged; Amphotericin B; Cefepime; Cephalosporins; D

2016
The clinical significance of erythema nodosum.
    Hospital practice (Office ed.), 1986, Mar-15, Volume: 21, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Antigen-Antibody Complex; Coccidioidomycosis; Diagnosis, Differenti

1986